Balaji Amines (530999) Panoramica del titolo
Balaji Amines Limited si occupa della produzione e della vendita di metilammine, etilammine e derivati di specialità chimiche ed eccipienti farmaceutici in India. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 1/6 |
| Crescita futura | 3/6 |
| Prestazioni passate | 4/6 |
| Salute finanziaria | 6/6 |
| Dividendi | 4/6 |
530999 Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Balaji Amines Limited
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | ₹2,275.55 |
| Massimo di 52 settimane | ₹2,627.95 |
| Minimo di 52 settimane | ₹905.15 |
| Beta | 0.86 |
| Variazione di 1 mese | 6.86% |
| Variazione a 3 mesi | 9.53% |
| Variazione di 1 anno | 52.85% |
| Variazione a 3 anni | 2.25% |
| Variazione a 5 anni | -50.43% |
| Variazione dall'IPO | 18,053.57% |
Notizie e aggiornamenti recenti
Aggiornamento narrativa • Jul 23
530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside
The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.
Aggiornamento narrativa • Jul 09
530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure
Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.Recent updates
Aggiornamento narrativa • Jul 23
530999: Rich Future P/E Expectations Will Likely Limit Share Price Upside
The analyst price target for Balaji Amines has shifted from ₹1,447.50 to ₹2,085.67. Analysts point to updated assumptions around revenue growth, profit margins, discount rate and future P/E expectations to support this change.Aggiornamento narrativa • Jul 09
530999: Higher Future P E Will Support Returns Despite Slight Margin Pressure
Analysts have raised their fair value estimate for Balaji Amines from ₹1,494 to ₹3,327, citing revised assumptions on the discount rate, revenue growth, profit margin and forward P/E as the key drivers of the updated price target. What’s in the News for Balaji Amines Balaji Amines has scheduled a Board Meeting on May 13, 2026.Aggiornamento narrativa • Jun 18
530999: Higher P E And Weaker Margins Will Pressure Future Returns
Analysts have raised their price target on Balaji Amines to ₹1,494 from ₹1,334, reflecting updated assumptions for revenue growth, profit margins and future P/E expectations. What’s in the News for Balaji Amines Balaji Amines has scheduled a board meeting for May 13, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026.Aggiornamento narrativa • May 21
530999: Lower Multiple Expectations Will Drive Cautious View Despite Margin Optimism
Analysts have trimmed their fair value estimate for Balaji Amines from ₹1,561 to ₹1,334, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 13, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommending a final dividend on equity shares for the financial year ended March 31, 2026, subject to shareholder approval at the 38th Annual General Meeting (Key Developments) Matters related to the upcoming 38th Annual General Meeting, including formal approvals and shareholder items, are also on the board meeting agenda (Key Developments) Valuation Changes Fair Value: Trimmed from ₹1,561 to ₹1,334, indicating a lower central estimate for the stock's worth based on updated assumptions.
Aggiornamento narrativa • May 07
530999: Higher Assumed Margins And P E Multiple Will Likely Limit Upside
Analysts have maintained their price target for Balaji Amines at ₹1,334. This reflects updated views based on a slightly lower discount rate, a modestly higher assumed revenue growth of 21.69% and a profit margin of 14.49%, as well as a revised future P/E assumption of 18.64x.Aggiornamento narrativa • Apr 23
530999: Higher Revenue Outlook And Lean Margins Will Support Future Upside
Analysts have trimmed their price target for Balaji Amines from ₹1,616.67 to ₹1,447.50, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E. Valuation Changes Fair Value: Trimmed from ₹1,616.67 to ₹1,447.50, indicating a lower central estimate for the share price.Aggiornamento narrativa • Apr 08
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have kept the price target for Balaji Amines steady at ₹1,561, citing slightly adjusted assumptions on the discount rate, revenue growth, profit margin and forward P/E as the main factors behind the unchanged view. What's in the News A board meeting is scheduled for January 29, 2026 to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Aggiornamento narrativa • Mar 24
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have maintained their fair value estimate for Balaji Amines at ₹1,334. The steady price target is supported by only small adjustments to the discount rate, revenue growth assumptions, profit margin and future P/E expectations.Aggiornamento narrativa • Mar 10
530999: Refined Margins And P E Assumptions Will Likely Support Returns
Analysts have kept their fair value estimate for Balaji Amines steady at ₹1,334, with small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions guiding this unchanged price target. What's in the News A board meeting is scheduled on Jan 29, 2026 to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Aggiornamento narrativa • Feb 23
530999: Higher Future P E And Margins Will Likely Support Returns
Analysts have maintained their price target for Balaji Amines at ₹1,334, reflecting a balance between a lower discount rate, slightly adjusted revenue growth assumptions, a modestly higher profit margin outlook, and a marginally higher future P/E multiple. What's in the News Board meeting scheduled for January 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended December 31, 2025.Aggiornamento narrativa • Feb 09
530999: Higher Margin Outlook And Upcoming Results Will Support Bullish Repricing
Analysts have revised their price target for Balaji Amines from ₹2,331 to ₹1,561, reflecting updated views on a lower assumed revenue growth rate, a slightly higher discount rate, a higher profit margin, and a reduced future P/E multiple. What's in the News Board meeting scheduled for Jan 29, 2026, to review and approve the unaudited standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Aggiornamento narrativa • Jan 25
530999: Richer Forward P/E Will Likely Support Returns Despite Thinner Margins
Analysts have raised their price target for Balaji Amines from ₹1,185 to ₹1,334, reflecting revised assumptions of higher revenue growth and a richer forward P/E multiple, partly offset by a lower profit margin outlook and a slightly higher discount rate. What's in the News Board meeting scheduled on Jan 29, 2026, to consider, approve and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Aggiornamento narrativa • Jan 10
530999: Stable Margins And Upcoming Results Will Support Further Upside
Analysts have maintained their price target for Balaji Amines at ₹1,616.67, reflecting largely unchanged assumptions on the discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for November 10, 2025, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2025 (company filing).Aggiornamento narrativa • Dec 25
530999 Will Likely See Slower Expansion Offset By Stronger Profit Margins
Analysts have reduced their fair value estimate for Balaji Amines to ₹1,185 from ₹1,598, citing expectations of slower revenue growth and a lower future P E multiple. This is partially offset by improved projected profit margins and a slightly higher discount rate.Aggiornamento narrativa • Dec 11
530999: Stable Margins And Growth Outlook Will Support Further Upside
Analysts have modestly lifted their price target on Balaji Amines to ₹1,616.67 per share, reflecting slightly higher assumed discount rates and steady long term growth and margin expectations that together support a marginally richer valuation multiple. What's in the News Board meeting scheduled on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Aggiornamento narrativa • Nov 27
530999: Rising Profit Margins Will Drive Further Upside Despite Slower Sales
Analysts have revised their price target for Balaji Amines downward from ₹1,847 to ₹1,617. This change is due to expectations of slower revenue growth, even though profit margin projections have improved.Aggiornamento narrativa • Sep 05
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
With both the Future P/E and Discount Rate showing only marginal changes, analysts have effectively maintained their valuation outlook for Balaji Amines, resulting in an unchanged consensus price target of ₹1847. What's in the News Board meeting scheduled to consider and approve un-audited standalone and consolidated financial results for the quarter ended 30 June 2025.
Nuova narrativa • Feb 02
New Plant Launches And Certifications Set To Drive Future Operational Efficiency And Revenue Potential
New plant expansions and strategic focus on high-margin products promise revenue growth and improved net margins through enhanced efficiency and diversification.Rendimenti per gli azionisti
| 530999 | IN Chemicals | IN Mercato | |
|---|---|---|---|
| 7D | -11.3% | -1.2% | -1.4% |
| 1Y | 52.8% | -1.6% | -1.2% |
Ritorno vs Industria: 530999 ha superato il Indian Chemicals che ha restituito -1.6 % nell'ultimo anno.
Rendimento vs Mercato: 530999 ha superato il mercato Indian che ha restituito -1.2 % nell'ultimo anno.
Volatilità dei prezzi
| 530999 volatility | |
|---|---|
| 530999 Average Weekly Movement | 7.7% |
| Chemicals Industry Average Movement | 5.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 8.9% |
| 10% least volatile stocks in IN Market | 3.4% |
Prezzo delle azioni stabile: Negli ultimi 3 mesi il prezzo delle azioni di 530999 è stato volatile rispetto al mercato Indian.
Volatilità nel tempo: La volatilità settimanale ( 8% ) di 530999 è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni Indian.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1988 | 1,161 | Dundurapu Reddy | www.balajiamines.com |
Balaji Amines Limited si occupa della produzione e della vendita di metilammine, etilammine e derivati di specialità chimiche ed eccipienti farmaceutici in India. L'azienda opera in due segmenti: chimico e alberghiero. L'azienda offre monometilammina, dimetilammina, trimetilammina, monoetilammina, dietilammina, trietilammina, dimetilamminoetanolo e dietilamminoetanolo; e specialità chimiche, tra cui N-metilpirrolidone, morfolina, 2-pirrolidone, N-etil-2-pirrolidone, gamma-butirrolattone, dimetilformammide, acetonitrile, dimetilcarbonato, glicole propilenico e carbonato propilenico.
Balaji Amines Limited Riepilogo dei fondamenti
| 530999 statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | ₹73.73b |
| Utili (TTM) | ₹2.04b |
| Ricavi(TTM) | ₹15.23b |
36.1x
Rapporto P/E4.8x
Rapporto P/S530999 è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| 530999 Conto economico (TTM) | |
|---|---|
| Ricavi | ₹15.23b |
| Costo del fatturato | ₹8.44b |
| Profitto lordo | ₹6.78b |
| Altre spese | ₹4.74b |
| Utili | ₹2.04b |
Ultimi utili riportati
Jun 30, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 63.00 |
| Margine lordo | 44.54% |
| Margine di profitto netto | 13.41% |
| Rapporto debito/patrimonio netto | 6.2% |
Come si è comportato 530999 nel lungo periodo?
Vedi performance storica e confrontoDividendi
0.5%
Rendimento attuale del dividendo21%
Rapporto di remunerazioneAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/09/14 14:47 |
| Prezzo dell'azione a fine giornata | 2026/09/11 00:00 |
| Utili | 2026/06/30 |
| Utili annuali | 2026/03/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Balaji Amines Limited è coperta da 4 analisti. 2 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Nilesh Ghuge | HDFC Securities Limited |
| Jay Gandhi | HDFC Securities Limited |
| Keshav Lahoti | HDFC Securities Limited |